Myomo Reports First Quarter 2019 Results
CAMBRIDGE, Mass., May 13, 2019 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced its financial results for the first quarter ended March 31, 2019. Read more.
Myomo® Announces New Distribution Agreement for Australia / New Zealand
CAMBRIDGE, Mass., May 1, 2019 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced that it has signed an agreement with NeuroMuscular Orthotics Pty Ltd (NMO) with the goal of offering MyoPro across […]
Myomo® to Present at Noble Capital Markets’ 15th Annual Investor Conference
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Myomo, Inc. (NYSE American: MYO) (“Myomo,” or the “Company”), a wearable medical robotics company, today announced that it will be presenting at NobleCon15 – Noble Capital Markets’ Fifteenth Annual Investor Conference at the W Hotel, Fort Lauderdale, Florida on Monday, January 28th at 10:30 AM EST – Studio 3. Chairman and Chief Executive […]
Myomo Reports Second Quarter 2018 Results
CAMBRIDGE, Mass., July 31, 2018 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company, today announced that it will release its financial results for the second quarter 2018 on Tuesday, August 7, 2018, after the US markets close. Read more.